Vance Forte

Boston Scientific Interventional Oncology Regional Sales Manager

[Peter Pattison @bsc_io_e]

💡 Join us at #AHPBA26 for an engaging discussion on building, strengthening, & optimizing multidisciplinary #HAItherapy programs. Hear from experts at established HAI therapy centers as they share practical strategies & actionable insights to elevate your team’s capabilities & improve patient outcomes. @AHPBA #MedEd #PatientOutcomes #HealthcareInnovation

[Nicholas Hornstein @GIMedOnc]

Unresectable intrahepatic cholangiocarcinoma (iCCA) remains brutal.
Gem/Cis alone → ~3% 3-year OS.

💥 PUMP-2 (JCO 2025) adds HAIP FUDR + Gem/Cis →
📈 Median OS 22.3 mo
💪 1-yr OS 80%
🔥 3-yr OS 31.5%

Not randomized, but striking signal. Pump trials aren’t easy; select patients, equipoise challenges, complex logistics.

But for liver-confined disease, regional therapy is an essential tool.

I helped launch the @NorthwellHealth Manhattan HAI program to deliver this safely and selectively, results like these remind us why.

@TheGutOncLab
@OncoAlert

https://t.co/V2ImjU96dh

[UK HealthCare @UK_HealthCare]

The UK Markey Cancer Center is the only healthcare facility in Kentucky that offers Hepatic Arterial Infusion. Learn more: https://t.co/TJTmBoPZ63

[Robert A Lookstein MD, MHCDL @roblookstein]

Live @MountSinaiIR great to see our own @kiremagarciamd and @DieHCCDie representing @IcahnMountSinai at this @ILCAnews event advancing loco-regional treatment for Hepatocellular Carcinoma

[Abhishek Kumar MD FSIR @AbhiKumar47]

Hot off the press! Multicenter collaboration--> Initial real world experience with Conformable embolic.

@RutgersIR @UChicagoIR @TheRealDoctorOs @Georgetown_IR

https://t.co/NeCp4vNuuD

[Rutgers IR @RutgersIR]

We are 15 days out! Still time to register! Join us for a comprehensive CME course on Transradial endovascular interventions! #embolization #pad #obl #io #pae #ufe #stroke

https://t.co/2K8DStFDrZ

[Vance Forte @vrforte]

#therasphere
#theraspheregbm
#frontier

[Peter Pattison @bsc_io_e]

NEW #FRONTIERstudy data presented by @SamMouli at #SIR25NASH Learn more about Frontier here: https://t.co/KKgIDDxKfW

#RecurrentGBM #ClinicalTrial #Glioblastoma #TheraSphereGBM

@NorthwesternIR

[Vance Forte @vrforte]

@MountSinaiIR @kiremagarciamd @JVIRmedia @vivianbishay @bonesz @roblookstein @SIRspecialists @DanSzeMDPhD Not surprised! Congrats KGR!

[Vance Forte @vrforte]

@bonesz @MountSinaiIR @SIRspecialists @DavidMauroMD @amishpatelmd @AbhiKumar47 @roblookstein @MountSinaiDMIR @MountSinaiNYC Congratulations to all of you ! Wonderful to see

[Vance Forte @vrforte]

@MountSinaiIR @roblookstein @kiremagarciamd @vivianbishay @bonesz @arianacmills @justine_aziz @jade_lerner @SidKulkarni3 @SIRspecialists @varun_danda Great photo

[Vance Forte @vrforte]

#therasphere

This particular y90 radioisotope continues to break barriers after 25 years, and will continue to do so.

[Peter Pattison @bsc_io_e]

Preview one of SIR's Abstracts of the Year! Hear from @SamMouli on the Frontier Study: Preliminary Results of Safety and Feasibility of Yttrium-90 TheraSphere in Recurrent Glioblastoma. Read here: https://t.co/jwxF4GKaGz

#TheraSphereGBM #Y90 #FRONTIERstudy #SIR2025 #Abstractoftheyear #Glioblastoma #RecurrentGBM #irad

@SIRspecialists
@NorthwesternIR

[Vance Forte @vrforte]

#thankyou #irad #glass

[Julius Chapiro @JuliusChapiro]

Nice add on the @SphereVegas in Vegas, @bostonsci @SIO_Central !

[Julius Chapiro @JuliusChapiro]

Nice add on the @SphereVegas in Vegas, @bostonsci @SIO_Central !

[Vance Forte @vrforte]

#SIOVegas

[Peter Pattison @bsc_io_e]

Excited to see many of you at #SIOVegas!

[Vance Forte @vrforte]

Never gets old to see the advancement(s) of Y90 Therasphere

[Peter Pattison @bsc_io_e]

Extremely pleased to share that we have completed initial enrollment for the #FRONTIERstudy. Thank you to the @NorthwesternIR team and to all of the FRONTIER sites for your dedication to this trial and to advancing treatment of recurrent GBM. Stay tuned for more #Y90 and #TheraSphereGBM updates. Sign up for updates here: https://t.co/FOQ2wPck1c

[Mount Sinai IR @MountSinaiIR]

Thank you @LewandowskiY90 for giving grand rounds about curative intent for HCC! Your insights and expertise are invaluable. The @MountSinaiIR team is grateful for your education and mentorship.

[Peter Pattison @bsc_io_e]

Exciting news! Upon close, the addition of this complementary therapy will allow us to provide treatment options for patients with both #HCC and #mCRC, which impacts 1.4 mil ppl in the US with 150k new cases diagnosed each yr. We look forward to the @InteraOncology team joining BSC and PI!

[GEST -Global Embolization Symposium & Technologies @thegestgroup]

Webinar: Revolutionizing Embolization - Patient and Case Selection with Obsidio™ Conformable Embolic. This cutting-edge session will explore the first-of-its-kind technology that's reshaping the landscape of embolization procedures.

Register for webinar on Oct 22 https://t.co/ndjWCuf8B1

#embolotherapy #interventionalradiology #embolization #IRads #MedEd #interventionaloncology

[Peter Pattison @bsc_io_e]

This #LiverCancerAwarenessMonth we would like to highlight the amazing work physicians from multiple disciplines have put into the #ROWANstudy. This ground-breaking trial for patients with #HCC could not be possible without the efforts of many physicians throughout the country. Learn more about the #ROWANstudy here: https://t.co/5LYbKDT6f6

#Y90 #Immunotherapy #LiverCancer #LCAM2024 #ClinicalTrials

Safety: https://t.co/IDLT70XUZz

[Peter Pattison @bsc_io_e]

Learn more about how #Obsidio #ConformableEmbolic is being used in practice. Hepatic artery embolization by @TheRealDoctorOs . See the full case library here: https://t.co/2Afpem29qE